Xtant Medical Holdings, Inc. financial data

Symbol
XTNT on NYSE
Location
Belgrade, MT
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 10 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 234% % -2.6%
Quick Ratio 127% % -8.6%
Debt-to-equity 115% % 14%
Return On Equity 3.8% %
Return On Assets 1.8% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 140,004,240 shares 0.72%
Common Stock, Shares, Outstanding 140,004,240 shares 0.95%
Entity Public Float $30,100,000 USD 17%
Weighted Average Number of Shares Outstanding, Basic 139,712,969 shares 3.4%
Weighted Average Number of Shares Outstanding, Diluted 150,377,234 shares 11%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $133,084,000 USD 17%
Research and Development Expense $2,164,000 USD -8.1%
Selling and Marketing Expense $46,251,000 USD -5.8%
General and Administrative Expense $27,782,000 USD -13%
Operating Income (Loss) $6,347,000 USD
Nonoperating Income (Expense) $4,087,000 USD -44%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $2,260,000 USD
Income Tax Expense (Benefit) $508,000 USD -32%
Net Income (Loss) Attributable to Parent $1,752,000 USD
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $10,400,000 USD 58%
Accounts Receivable, after Allowance for Credit Loss, Current $25,517,000 USD 24%
Inventory, Net $40,714,000 USD -2.8%
Assets, Current $78,330,000 USD 9.7%
Property, Plant and Equipment, Net $10,009,000 USD -2.7%
Operating Lease, Right-of-Use Asset $3,619,000 USD 264%
Intangible Assets, Net (Excluding Goodwill) $7,060,000 USD -20%
Goodwill $7,302,000 USD 0%
Other Assets, Noncurrent $1,000 USD -99%
Assets $106,321,000 USD 7.5%
Accounts Payable, Current $6,856,000 USD -17%
Accrued Liabilities, Current $11,535,000 USD 30%
Liabilities, Current $35,503,000 USD 5.4%
Deferred Income Tax Liabilities, Net $42,000 USD 100%
Operating Lease, Liability, Noncurrent $2,949,000 USD 1094%
Other Liabilities, Noncurrent $38,000 USD
Liabilities $55,938,000 USD 5.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax $139,000 USD 157%
Retained Earnings (Accumulated Deficit) $254,543,000 USD 0.68%
Stockholders' Equity Attributable to Parent $50,383,000 USD 10%
Liabilities and Equity $106,321,000 USD 7.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,278,000 USD
Net Cash Provided by (Used in) Financing Activities $919,000 USD -118%
Net Cash Provided by (Used in) Investing Activities $1,143,000 USD -70%
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 140,004,240 shares 0.95%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $786,000 USD 39%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $10,641,000 USD 50%
Interest Paid, Excluding Capitalized Interest, Operating Activities $882,000 USD 19%
Deferred Tax Assets, Valuation Allowance $28,949,000 USD 12%
Deferred Tax Assets, Gross $29,662,000 USD 12%
Operating Lease, Liability $3,709,000 USD
Depreciation $2,800,000 USD 17%
Payments to Acquire Property, Plant, and Equipment $1,191,000 USD 54%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $1,837,000 USD
Lessee, Operating Lease, Liability, to be Paid $4,721,000 USD
Property, Plant and Equipment, Gross $31,869,000 USD 1.9%
Operating Lease, Liability, Current $760,000 USD -4.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two $925,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $1,035,000 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,012,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three $893,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $19,160,000 USD 2.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $874,000 USD
Additional Paid in Capital $304,787,000 USD 0.93%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $400,000 USD 0%
Depreciation, Depletion and Amortization $1,074,000 USD 6.9%
Interest Expense $1,004,000 USD 1.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%